In this study, we found that AR expression was associated with a reduction in primary tumor CD90+ populations, a reduction in cancer cell migration, and an increase in CTC death, indicating that increased expression of AR might protect against postoperative HCC recurrence. Here, AR is linked to hepatocellular carcinoma.